Julie Dawson

2.1k total citations · 1 hit paper
31 papers, 1.3k citations indexed

About

Julie Dawson is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Physiology. According to data from OpenAlex, Julie Dawson has authored 31 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 12 papers in Rheumatology and 11 papers in Physiology. Recurrent topics in Julie Dawson's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (24 papers), Rheumatoid Arthritis Research and Therapies (11 papers) and Sarcoidosis and Beryllium Toxicity Research (11 papers). Julie Dawson is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (24 papers), Rheumatoid Arthritis Research and Therapies (11 papers) and Sarcoidosis and Beryllium Toxicity Research (11 papers). Julie Dawson collaborates with scholars based in United Kingdom and United States. Julie Dawson's co-authors include N. Sathi, Felix Woodhead, Clive Kelly, Gouri Koduri, S. Arthanari, Muhammad K Nisar, Yasmeen Ahmad, A. Young, V. Saravanan and Steven Lane and has published in prestigious journals such as Annals of the Rheumatic Diseases, Thorax and Lara D. Veeken.

In The Last Decade

Julie Dawson

30 papers receiving 1.2k citations

Hit Papers

Rheumatoid arthritis-rela... 2014 2026 2018 2022 2014 100 200 300

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Julie Dawson 1.0k 591 500 300 277 31 1.3k
Roland du Bois 1.0k 1.0× 736 1.2× 141 0.3× 269 0.9× 214 0.8× 23 1.3k
Yimy F. Medina 529 0.5× 317 0.5× 396 0.8× 169 0.6× 145 0.5× 29 761
Anand Devaraj 1.5k 1.5× 638 1.1× 195 0.4× 282 0.9× 411 1.5× 18 1.7k
Janet Roddy 755 0.8× 113 0.2× 223 0.4× 369 1.2× 1.1k 3.8× 52 1.5k
P. Pantelidis 866 0.9× 254 0.4× 81 0.2× 259 0.9× 504 1.8× 14 1.0k
J Mooney 537 0.5× 165 0.3× 357 0.7× 55 0.2× 52 0.2× 11 730
L. Guillevin 253 0.3× 74 0.1× 144 0.3× 158 0.5× 249 0.9× 28 678
Alessandro Tomelleri 547 0.5× 199 0.3× 491 1.0× 101 0.3× 116 0.4× 84 1.4k
T. Ponge 467 0.5× 115 0.2× 364 0.7× 67 0.2× 111 0.4× 48 684
Punyasha Roul 198 0.2× 129 0.2× 258 0.5× 89 0.3× 61 0.2× 35 508

Countries citing papers authored by Julie Dawson

Since Specialization
Citations

This map shows the geographic impact of Julie Dawson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Dawson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Dawson more than expected).

Fields of papers citing papers by Julie Dawson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Dawson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Dawson. The network helps show where Julie Dawson may publish in the future.

Co-authorship network of co-authors of Julie Dawson

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Dawson. A scholar is included among the top collaborators of Julie Dawson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Dawson. Julie Dawson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dawson, Julie, et al.. (2021). Does methotrexate cause progressive fibrotic interstitial lung disease? A systematic review. Rheumatology International. 41(6). 1055–1064. 18 indexed citations
2.
Dawson, Julie, et al.. (2019). Systematic literature review investigating whether methotrexate causes chronic pulmonary fibrosis. Future Healthcare Journal. 6. s4–s4. 1 indexed citations
4.
Kelly, Clive, Adam Young, Yasmeen Ahmad, et al.. (2016). 092 The Effect of Steroids, Azathioprine and Mycophenolate on the Risk of Death in Rheumatoid Lung Disease. Lara D. Veeken. 5 indexed citations
5.
Gordon, Judith R., David Middleton, Adam Young, et al.. (2015). 068. Cyclophosphamide in the Treatment of Severe Interstitial Lung Disease in Patients with Rheumatoid Arthritis. Lara D. Veeken. 1 indexed citations
6.
Kelly, Clive, V. Saravanan, Muhammad K Nisar, et al.. (2014). Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics--a large multicentre UK study. Lara D. Veeken. 53(9). 1676–1682. 377 indexed citations breakdown →
7.
Kelly, Clive, Mohamed Nisar, Subha Arthanari, et al.. (2014). O36. Rheumatoid-Arthritis-Related Interstitial Lung Disease: Association Between Biologic Therapy and Survival. Lara D. Veeken. 53(suppl_1). i44–i44. 4 indexed citations
8.
Brown, Matthew A., Clive Kelly, Muhammad K Nisar, et al.. (2014). SAT0130 Rheumatoid Arthritis Related Interstitial Lung Disease – is There an Association between Disease Modifying anti Rheumatic Drugs and Survival?. Annals of the Rheumatic Diseases. 73. 637–637. 1 indexed citations
9.
Kelly, Carol, Eva K.F. Chan, Muhammad K Nisar, et al.. (2013). FRI0114 Rheumatoid arthritis related interstitial lung disease – relevance of lung function tests and high resolution computed tomography in a large multi centre series. Annals of the Rheumatic Diseases. 72. A408–A409. 1 indexed citations
10.
Patel, Vishal, Preeti Patel, & Julie Dawson. (2012). Comment on: Non-infectious pulmonary toxicity of rituximab: a systematic review. Lara D. Veeken. 51(11). 2111–2112.
11.
Dawson, Julie, et al.. (2012). THU0081 Assessing the cardiovascular risk burden in patients with rheumatoid arthritis: Role of annual review clinic. Annals of the Rheumatic Diseases. 71. 180–180. 1 indexed citations
12.
Sathi, N., et al.. (2011). How common is methotrexate pneumonitis? A large prospective study investigates. Clinical Rheumatology. 31(1). 79–83. 43 indexed citations
13.
Lane, Steven, et al.. (2009). Clinical expression of leflunomide-induced pneumonitis. Lara D. Veeken. 48(9). 1065–1068. 63 indexed citations
14.
Sathi, N., et al.. (2008). Variation of immunological response in methotrexate-induced pneumonitis. Lara D. Veeken. 47(11). 1647–1650. 35 indexed citations
15.
Moots, Robert J., Julie Dawson, R. N. Thompson, et al.. (2005). Rheumatoid arthritis - treatment [112-148]. British journal of rheumatology. 44(suppl_1). i64–i76. 1 indexed citations
16.
Dawson, Julie, et al.. (2002). Predictors of progression of HRCT diagnosed fibrosing alveolitis in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 61(6). 517–521. 101 indexed citations
19.
Dawson, Julie. (2000). Raised pulmonary artery pressures measured with Doppler echocardiography in rheumatoid arthritis patients. British journal of rheumatology. 39(12). 1320–1325. 82 indexed citations
20.
Rhodes, J., R Cockel, R N Allan, et al.. (1984). Colonic Crohn's disease and use of oral contraception.. BMJ. 288(6417). 595–596. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026